By Dr Toby Nicholas Trahair

Journal articles

Hastings JF; Latham SL; Kamili A; Wheatley MS; Han JZR; Wong-Erasmus M; Phimmachanh M; Nobis M; Pantarelli C; Cadell AL; O’Donnell YEI; Leong KH; Lynn S; Geng FS; Cui L; Yan S; Achinger-Kawecka J; Stirzaker C; Norris MD; Haber M; Trahair TN; Speleman F; De Preter K; Cowley MJ; Bogdanovic O; Timpson P; Cox TR; Kolch W; Fletcher JI; Fey D; Croucher DR, 2023, 'Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma', Science Advances, vol. 9, pp. eabp8314, http://dx.doi.org/10.1126/sciadv.abp8314

Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RDA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN, 2022, 'Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia', BMC Cancer, vol. 22, http://dx.doi.org/10.1186/s12885-022-10072-x

Greenwood M; Gangatharan S; Osborn MP; Ng AP; Fleming S; Fedele P; Trahair T; Casey J; Mapp S; Cheung C; Armytage T; Henderson M; Sutton R; McCloud P; Larsen SR; Presgrave P; Kwan J; Bennett S; Fong CY; Dalla Pozza L, 2022, 'Blinatumomab in Combination with an Intensive Pediatric Protocol Results in High Rates of Day 79 MRD Negativity in Adolescent and Young Adult Acute Lymphoblastic Leukemia - Preliminary Results of the Australasian Leukaemia and Lymphoma Group (ALLG) ALL09 "Sublime” Study', Blood, vol. 140, pp. 8971 - 8972, http://dx.doi.org/10.1182/blood-2022-168568

Sorrentino S; Ash S; Haupt R; Plantaz D; Schiff I; Hero B; Simon T; Kachanov D; Shamanskaya T; Kraal K; Littooij A; Wieczoreck A; Balwierz W; Laureys G; Trager C; Sertorio F; Erminio G; Fragola M; Beck Popovic M; De Bernardi B; Trahair T, 2022, 'Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN)', Frontiers in Pediatrics, vol. 10, pp. 1023498, http://dx.doi.org/10.3389/fped.2022.1023498

Pearson HCL; Hunt KV; Trahair TN; Lock RB; Lee HJ; De Bock CE, 2022, 'The Promise of Single-cell Technology in Providing New Insights into the Molecular Heterogeneity and Management of Acute Lymphoblastic Leukemia', HemaSphere, vol. 6, pp. E734, http://dx.doi.org/10.1097/HS9.0000000000000734

Doculara L; Trahair TN; Bayat N; Lock RB, 2022, 'Circulating Tumor DNA in Pediatric Cancer', Frontiers in Molecular Biosciences, vol. 9, http://dx.doi.org/10.3389/fmolb.2022.885597

Lau LMS; Mayoh C; Xie J; Barahona P; MacKenzie KL; Wong M; Kamili A; Tsoli M; Failes TW; Kumar A; Mould EVA; Gifford A; Chow SO; Pinese M; Fletcher JI; Arndt GM; Khuong-Quang DA; Wadham C; Batey D; Eden G; Trebilcock P; Joshi S; Alfred S; Gopalakrishnan A; Khan A; Grebert Wade D; Strong PA; Manouvrier E; Morgan LT; Span M; Lim JY; Cadiz R; Ung C; Thomas DM; Tucker KM; Warby M; McCowage GB; Dalla-Pozza L; Byrne JA; Saletta F; Fellowes A; Fox SB; Norris MD; Tyrrell V; Trahair TN; Lock RB; Cowley MJ; Ekert PG; Haber M; Ziegler DS; Marshall GM, 2022, 'In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer', EMBO Molecular Medicine, vol. 14, http://dx.doi.org/10.15252/emmm.202114608

Schilstra CE; Sansom-Daly UM; Schaffer M; Fardell JE; Anazodo AC; McCowage G; Fletcher JI; Marshall GM; Buchhorn-White J; Evtushenko M; Trahair TN; Ellis SJ, 2022, '"we Have All This Knowledge to Give, so Use Us as a Resource": Partnering with Adolescent and Young Adult Cancer Survivors to Determine Consumer-Led Research Priorities', Journal of Adolescent and Young Adult Oncology, vol. 11, pp. 211 - 222, http://dx.doi.org/10.1089/jayao.2021.0052

Schilstra CE; Fardell JE; Ellis SJ; Jones KM; Anazodo AC; Trahair TN; Lah S; Cohn RJ; Wakefield CE; Sansom-Daly UM, 2022, 'Social Anxiety Symptoms in Survivors of Childhood and Adolescent Cancer', Journal of Adolescent and Young Adult Oncology, vol. 11, pp. 129 - 137, http://dx.doi.org/10.1089/jayao.2021.0050

Mateos MK; Marshall GM; Barbaro PM; Quinn MCJ; George C; Mayoh C; Sutton R; Revesz T; Giles JE; Barbaric D; Alvaro F; Mechinaud F; Catchpoole D; Lawson JA; Chenevix-Trench G; MacGregor S; Kotecha RS; Dalla-Pozza L; Trahair TN, 2022, 'Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia', Haematologica, vol. 107, pp. 635 - 643, http://dx.doi.org/10.3324/haematol.2020.268565

Mesbahi Y; Trahair TN; Lock RB; Connerty P, 2022, 'Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells', Frontiers in Oncology, vol. 12, http://dx.doi.org/10.3389/fonc.2022.807266

Venn NC; Huang L; Hovorková L; Muskovic W; Wong M; Law T; Heatley SL; Khaw SL; Revesz T; Dalla Pozza L; Shaw PJ; Fraser C; Moore AS; Cross S; Bendak K; Norris MD; Henderson MJ; White DL; Cowley MJ; Trahair TN; Zuna J; Sutton R, 2022, 'Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions', British Journal of Cancer, http://dx.doi.org/10.1038/s41416-022-01806-6

Greenwood M; Trahair T; Sutton R; Osborn M; Kwan J; Mapp S; Howman R; Anazodo A; Wylie B; D’Rozario J; Hertzberg M; Irving I; Yeung D; Coyle L; Jager A; Engeler D; Venn N; Frampton C; Wei AH; Bradstock K; Dalla-Pozza L, 2021, 'An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL', Blood Advances, vol. 5, pp. 5574 - 5583, http://dx.doi.org/10.1182/bloodadvances.2021005576

Nagabushan S; Lau LMS; Barahona P; Wong M; Sherstyuk A; Marshall GM; Tyrrell V; Wegner EA; Ekert PG; Cowley MJ; Mayoh C; Trahair TN; Crowe P; Anazodo A; Ziegler DS, 2021, 'Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor', npj Precision Oncology, vol. 5, http://dx.doi.org/10.1038/s41698-021-00145-8

Pearson ADJ; Barry E; Mossé YP; Ligas F; Bird N; de Rojas T; Zimmerman ZF; Wilner K; Woessmann W; Weiner S; Weigel B; Venkatramani R; Valteau D; Trahair T; Smith M; Singh S; Selvaggi G; Scobie N; Schleiermacher G; Richardson N; Park J; Nysom K; Norga K; Merino M; McDonough J; Matloub Y; Marshall LV; Lowe E; Lesa G; Irwin M; Karres D; Gajjar A; Doz F; Fox E; DuBois SG; Donoghue M; Casanova M; Caron H; Buenger V; Bradford D; Blanc P; Barone A; Reaman G; Vassal G, 2021, 'Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration', European Journal of Cancer, vol. 157, pp. 198 - 213, http://dx.doi.org/10.1016/j.ejca.2021.08.022

Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML, 2021, 'Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study', The Lancet Haematology, vol. 8, pp. e700 - e710, http://dx.doi.org/10.1016/S2352-3026(21)00272-6

Garaventa A; Poetschger U; Valteau-Couanet D; Luksch R; Castel V; Elliott M; Ash S; Chan GCF; Laureys G; Beck-Popovic M; Vettenranta K; Balwierz W; Schroeder H; Owens C; Cesen M; Papadakis V; Trahair T; Schleiermacher G; Ambros P; Sorrentino S; Pearson ADJ; Ladenstein RL, 2021, 'Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study', Journal of Clinical Oncology, vol. 39, pp. 2552 - 2563, http://dx.doi.org/10.1200/JCO.20.03144

Michniewicz F; Saletta F; Rouaen JRC; Hewavisenti RV; Mercatelli D; Cirillo G; Giorgi FM; Trahair T; Ziegler D; Vittorio O, 2021, 'Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics', ChemMedChem, vol. 16, pp. 2315 - 2329, http://dx.doi.org/10.1002/cmdc.202100172

Chen D; Sutton R; Giles J; Venn NC; Huang L; Law T; Subhash VV; Trahair TN; Henderson MJ, 2021, 'Analytical Quality Controls for ddPCR Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia', CLINICAL CHEMISTRY, vol. 67, pp. 1373 - 1383, http://dx.doi.org/10.1093/clinchem/hvab117

Mahajan P; Casanova M; Ferrari A; Fordham A; Trahair T; Venkatramani R, 2021, 'Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges', Current Problems in Cancer, vol. 45, http://dx.doi.org/10.1016/j.currproblcancer.2021.100768

Andrés-Jensen L; Attarbaschi A; Bardi E; Barzilai-Birenboim S; Bhojwani D; Hagleitner MM; Halsey C; Harila-Saari A; van Litsenburg RRL; Hudson MM; Jeha S; Kato M; Kremer L; Mlynarski W; Möricke A; Pieters R; Piette C; Raetz E; Ronceray L; Toro C; Grazia Valsecchi M; Vrooman LM; Weinreb S; Winick N; Schmiegelow K; Adams MR; Baust K; Boesten T; Calaminus G; Conyers R; Darlington AS; de Ville M; Escherich G; Hou JY; Huang TH; Hudson M; Jenney M; Krawczuk-Rybak M; Kremer L; Lautem M; Liu HC; Lopez Lopez E; Mateos M; Muszynska-Roslan K; Niinimaki R; Trahair T; van der Sluis I; Wiener A; Yano M; Yeh TC; Zapotocka E, 2021, 'Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia', The Lancet Haematology, vol. 8, pp. e513 - e523, http://dx.doi.org/10.1016/S2352-3026(21)00136-8

Sutton R; Pozza LD; Khaw SL; Fraser C; Revesz T; Chamberlain J; Mitchell R; Trahair TN; Bateman CM; Venn NC; Law T; Ong E; Heatley SL; McClure BJ; Meyer C; Marschalek R; Henderson MJ; Cross S; White DL; Kotecha RS, 2021, 'Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab', Pediatric Blood and Cancer, vol. 68, pp. e28922, http://dx.doi.org/10.1002/pbc.28922

Putra V; Hulme AJ; Tee AE; Sun JQJ; Atmadibrata B; Ho N; Chen J; Gao J; Norris MD; Haber M; Kavallaris M; Henderson MJ; McCarroll J; Trahair T; Liu T; Liu PY, 2021, 'The RNA-helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma', Molecular Oncology, vol. 15, pp. 1162 - 1179, http://dx.doi.org/10.1002/1878-0261.12906

Chen J; Nelson C; Wong M; Tee AE; Liu PY; La T; Fletcher JI; Kamili A; Mayoh C; Bartenhagen C; Trahair TN; Xu N; Jayatilleke N; Wong M; Peng H; Atmadibrata B; Cheung BB; Lan Q; Bryan TM; Mestdagh P; Vandesompele J; Combaret V; Boeva V; Wang JY; Janoueix-Lerosey I; Cowley MJ; MacKenzie KL; Dolnikov A; Li J; Polly P; Marshall GM; Reddel RR; Norris MD; Haber M; Fischer M; Zhang XD; Pickett HA; Liu T, 2021, 'Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy', Clinical Cancer Research, vol. 27, pp. 1438 - 1451, http://dx.doi.org/10.1158/1078-0432.CCR-20-3044

Berlanga P; Pasqualini C; Pötschger U; Sangüesa C; Castellani MR; Cañete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R, 2021, 'Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience', European Journal of Cancer, vol. 144, pp. 1 - 8, http://dx.doi.org/10.1016/j.ejca.2020.10.020

Lapirow D; La Gerche A; Toro C; Masango E; Costello B; Porello E; Ludlow L; Marshall G; Trahair T; Mateos M; Lewin J; Byrne J; Boutros R; Manudhane R; Heath J; Ayer J; Gabriel M; Walwyn T; Saundankar J; Forsey J; Le H; Mason K; Celermajer D; Downie P; Walker R; Holland L; Martin M; McLeman L; Diamond Y; Marcocci M; Donath S; Cheung M; Elliott DA; Conyers R, 2021, 'The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients', Internal Medicine Journal, vol. 51, pp. 229 - 234, http://dx.doi.org/10.1111/imj.14719

Schilstra CE; Fardell JE; Burns MA; Ellis SJ; Anazodo AC; Trahair TN; Sansom-Daly UM, 2021, 'Determinants of social functioning among adolescents and young adults with cancer: A systematic review', Psycho-Oncology, http://dx.doi.org/10.1002/pon.5740

Tan O; Schofield DJ; O’Brien T; Trahair T; Shrestha RN, 2021, 'Modelling the Economic Impact of Next Generation Sequencing and Precision Medicine on Childhood Cancer Management—a Microsimulation Approach', International Journal of Microsimulation, vol. 14, pp. 73 - 91, http://dx.doi.org/10.34196/ijm.00230

Subhash VV; Huang L; Kamili A; Wong M; Chen D; Venn NC; Atkinson C; Mayoh C; Venkat P; Tyrrell V; Marshall GM; Cowley MJ; Ekert PG; Norris MD; Haber M; Henderson MJ; Sutton R; Fletcher JI; Trahair TN, 2021, 'Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma', British Journal of Cancer, http://dx.doi.org/10.1038/s41416-021-01538-z

Wong M; Mayoh C; Lau LMS; Khuong-Quang DA; Pinese M; Kumar A; Barahona P; Wilkie EE; Sullivan P; Bowen-James R; Syed M; Martincorena I; Abascal F; Sherstyuk A; Bolanos NA; Baber J; Priestley P; Dolman MEM; Fleuren EDG; Gauthier ME; Mould EVA; Gayevskiy V; Gifford AJ; Grebert-Wade D; Strong PA; Manouvrier E; Warby M; Thomas DM; Kirk J; Tucker K; O’Brien T; Alvaro F; McCowage GB; Dalla-Pozza L; Gottardo NG; Tapp H; Wood P; Khaw SL; Hansford JR; Moore AS; Norris MD; Trahair TN; Lock RB; Tyrrell V; Haber M; Marshall GM; Ziegler DS; Ekert PG; Cowley MJ, 2020, 'Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer', Nature Medicine, vol. 26, pp. 1742 - 1753, http://dx.doi.org/10.1038/s41591-020-1072-4

Fordham AM; Xie J; Gifford AJ; Wadham C; Morgan LT; Mould EVA; Fadia M; Zhai L; Massudi H; Ali ZS; Marshall GM; Lukeis RE; Fletcher JI; MacKenzie KL; Trahair TN, 2020, 'CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma', British Journal of Cancer, vol. 123, pp. 1101 - 1113, http://dx.doi.org/10.1038/s41416-020-0996-2

Lee S; Nath CE; Balzer BWR; Lewis CR; Trahair TN; Anazodo AC; Shaw PJ, 2020, 'An HPLC-PDA Method for Determination of Alectinib Concentrations in the Plasma of an Adolescent', Acta Chromatographica, vol. 32, pp. 166 - 169, http://dx.doi.org/10.1556/1326.2019.00578

Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY, 2020, 'Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia', Cancer Cell, vol. 38, pp. 263 - 278.e6, http://dx.doi.org/10.1016/j.ccell.2020.05.014

Mateos MK; Tulstrup M; Quinn MCJ; Tuckuviene R; Marshall GM; Gupta R; Mayoh C; Wolthers BO; Barbaro PM; Ruud E; Sutton R; Huttunen P; Revesz T; Trakymiene SS; Barbaric D; Tedgård U; Giles JE; Alvaro F; Jonsson OG; Mechinaud F; Saks K; Catchpoole D; Kotecha RS; Dalla-Pozza L; Chenevix-Trench G; Trahair TN; Macgregor S; Schmiegelow K, 2020, 'Genome-wide association meta-analysis of single-nucleotide polymorphisms and symptomatic venous thromboembolism during therapy for acute lymphoblastic leukemia and lymphoma in caucasian children', Cancers, vol. 12, http://dx.doi.org/10.3390/cancers12051285

Mckenna JE; Trahair T, 2020, 'Bronchial carcinoid tumour identified as the cause for recurrent pneumonia in a 10-year-old boy', Journal of Paediatrics and Child Health, vol. 56, pp. 642 - 644, http://dx.doi.org/10.1111/jpc.14623

Berry NK; Scott RJ; Sutton R; Law T; Trahair TN; Dalla-Pozza L; Ritchie P; Barbaric D; Enjeti AK, 2020, 'Enrichment of atypical hyperdiploidy and IKZF1 deletions detected by SNP-microarray in high-risk Australian AIEOP-BFM B-cell acute lymphoblastic leukaemia cohort', Cancer Genetics, vol. 242, pp. 8 - 14, http://dx.doi.org/10.1016/j.cancergen.2020.01.051

Xie J; Span M; van Maarseveen E; Langenhorst J; Boddy AV; Sia KCS; Sutton R; Venn N; Punt AM; Tyrrell V; Haber M; Trahair T; Lau L; Marshall GM; Lock RB, 2020, 'Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia', Pediatric Blood and Cancer, vol. 67, pp. e28133, http://dx.doi.org/10.1002/pbc.28133

Ladenstein R; Pötschger U; Valteau-couanet D; Luksch R; Castel V; Ash S; Laureys G; Brock P; Michon JM; Owens C; Trahair T; Chan GCF; Ruud E; Schroeder H; Beck-popovic M; Schreier G; Loibner H; Ambros P; Holmes K; Castellani MR; Gaze MN; Garaventa A; Pearson ADJ; Lode HN, 2020, 'Investigation of the role of dinutuximab beta-based immunotherapy in the siopen high-risk neuroblastoma 1 trial (HR-NBL1)', Cancers, vol. 12, http://dx.doi.org/10.3390/cancers12020309

Kamili A; Atkinson C; Trahair TN; Fletcher JI, 2020, 'Mouse models of high-risk neuroblastoma', Cancer and Metastasis Reviews, http://dx.doi.org/10.1007/s10555-020-09855-0

Kamili A; Gifford AJ; Li N; Mayoh C; Chow S-O; Failes TW; Eden GL; Cadiz R; Xie J; Lukeis RE; Norris MD; Haber M; McCowage GB; Arndt GM; Trahair TN; Fletcher JI, 2020, 'Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy', British Journal of Cancer, http://dx.doi.org/10.1038/s41416-019-0682-4

Holmes K; Pötschger U; Pearson ADJ; Sarnacki S; Cecchetto G; Gomez-Chacon J; Squire R; Freud E; Bysiek A; Matthyssens LE; Metzelder M; Monclair T; Stenman J; Rygl M; Rasmussen L; Joseph JM; Irtan S; Avanzini S; Godzinski J; Björnland K; Elliott M; Luksch R; Castel V; Ash S; Balwierz W; Laureys G; Ruud E; Papadakis V; Malis J; Owens C; Schroeder H; Beck-Popovic M; Trahair T; de Lacerda AF; Ambros PF; Gaze MN; McHugh K; Valteau-Couanet D; Ladenstein RL, 2020, 'Influence of Surgical Excision on the Survival of Patients with Stage 4 High-Risk Neuroblastoma: A Report from the HR-NBL1/SIOPEN Study', Journal of Clinical Oncology, vol. 38, pp. 2902 - 2915, http://dx.doi.org/10.1200/JCO.19.03117

Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY, 2019, 'JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis', Leukemia, vol. 33, pp. 1400 - 1410, http://dx.doi.org/10.1038/s41375-018-0354-z

Mateos MK; Trahair TN; Mayoh C; Barbaro PM; Sutton R; Revesz T; Barbaric D; Giles JE; Alvaro F; Mechinaud F; Catchpoole D; Kotecha RS; Dalla-Pozza L; Quinn MCJ; MacGregor S; Chenevix-Trench G; Marshall GM, 2019, 'Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia', Thrombosis Research, vol. 178, pp. 132 - 138, http://dx.doi.org/10.1016/j.thromres.2019.04.011

Boutros R; Catchpoole D; Collins K; Cross S; Downie P; Drinkwater C; Fletcher J; Gottardo N; Hunter S; Kirby M; Ludlow L; MacNish M; Maybury M; Moore A; Morrin H; Purdy S; Revesz T; Saffery R; Strong R; Trahair T; Wood A; Byrne J, 2019, 'The Australian and New Zealand Children's Haematology/Oncology Group Biobanking Network', Biopreservation and Biobanking, vol. 17, pp. 95 - 97, http://dx.doi.org/10.1089/bio.2019.0013

Gamble LD; Purgato S; Murray J; Xiao L; Yu DMT; Hanssen KM; Giorgi FM; Carter DR; Gifford AJ; Valli E; Milazzo G; Kamili A; Mayoh C; Liu B; Eden G; Sarraf S; Allan S; Giacomo SD; Flemming CL; Russell AJ; Cheung BB; Oberthuer A; London WB; Fischer M; Trahair TN; Fletcher JI; Marshall GM; Ziegler DS; Hogarty MD; Burns MR; Perini G; Norris MD; Haber M, 2019, 'Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma', Science Translational Medicine, vol. 11, http://dx.doi.org/10.1126/scitranslmed.aau1099

Trahair T; Gifford AJ; Fordham A; Mayoh C; Fadia M; Lukeis R; Wood AC; Valvi S; Walker RD; Blackburn J; Heyer EE; Mercer TR; Barbaric D; Marshall GM; MacKenzie KL, 2019, 'Crizotinib and surgery for long-term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumors', JCO Precision Oncology, vol. 3, pp. 1 - 11, http://dx.doi.org/10.1200/PO.18.00297

Greenwood M; Trahair T; Osborn M; Sutton R; Kwan J; Mapp S; Burt A; Jager A; Frampton C; Wei A; Bradstock K; Dalla-Pozza L, 2019, 'PS938 INTENSIVE PAEDIATRIC THERAPY IS AS DELIVERABLE IN ADOLESCENTS AND YOUNG ADULTS AS CHILDREN WITH ALL - PRELIMINARY RESULTS OF THE AUSTRALASIAN LEUKAEMIA AND LYMPHOMA GROUP (ALLG) ALL06 STUDY', HemaSphere, vol. 3, pp. 422 - 422, http://dx.doi.org/10.1097/01.hs9.0000562024.31781.2a

Balzer B; Loo C; Wegner E; Nath C; Lee S; Smith C; Lewis C; Trahair T; Anazodo A, 2018, 'Alectinib is effective, safe and tolerable in an adolescent with stage IVB ALK-rearranged adenocarcinoma of the lung.', Pediatric Hematology-Oncology, pp. 1 - 7, http://dx.doi.org/10.1080/08880018.2018.1541492

Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS, 2018, 'Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer', Cancer Biology and Therapy, vol. 19, pp. 1078 - 1087, http://dx.doi.org/10.1080/15384047.2018.1491498

Ladenstein R; Pötschger U; Valteau-Couanet D; Luksch R; Castel V; Yaniv I; Laureys G; Brock P; Michon JM; Owens C; Trahair T; Chan GCF; Ruud E; Schroeder H; Beck Popovic M; Schreier G; Loibner H; Ambros P; Holmes K; Castellani MR; Gaze MN; Garaventa A; Pearson ADJ; Lode HN, 2018, 'Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial', The Lancet Oncology, vol. 19, pp. 1617 - 1629, http://dx.doi.org/10.1016/S1470-2045(18)30578-3

Back to profile page